Results 71 to 80 of about 18,786 (126)

Efficacy and safety of ketogenic diet in glioblastoma: an updated systematic review and meta-analysis. [PDF]

Neurol Sci
Firdous J, Asif AE, Haris HM, Iqbal U, Khalid M, Zahid HF, Mubarika M, Abufatima IO, Amin MHJ, Hafeez S, Jabeen F, Shahzaib M, Fatima N, Kumar N, Sen S, Hassan A.   +15 more
europepmc   +1 more source

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors. [PDF]

Neurooncol Adv
Nakhate V, Westergaard C, Lan Z, Lasica AB, Muzikansky A, Barlow B, Russ A, Aker L, Jiao A, Pan I, Nelson TA, Nwagwu CD, Aquilanti E, Batchelor TT, Beroukhim R, Berger TR, Chukwueke U, Castro LNG, Lee EQ, Mcfaline-Figueroa JR, Nayak L, Rhee JY, Reardon DA, Huang RY, Wen PY, Youssef G.   +25 more
europepmc   +1 more source

Metabolic and Post-Translational Vulnerabilities of Glioblastoma: Disulfidptosis, Glycosylation, and Implications for CAR-T Therapy. [PDF]

Cells
Strózik T, Rutkowska A, Wasiak T, Ciunowicz D, Rieske P, Szczepaniak N, Stoczyńska-Fidelus E.   +6 more
europepmc   +1 more source

Chronic IFN-γ Exposure Induces Divergent Adaptive Programs in Glioblastoma Subtypes. [PDF]

Cancers (Basel)
Rahbarlayegh E, Nomura N, Juarez TM, Kesari PR, Kesari S.   +4 more
europepmc   +1 more source

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study. [PDF]

J Neurooncol
Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO.   +10 more
europepmc   +1 more source

Conditional survival in glioblastoma: The evolution of prognostic factors over time. [PDF]

Int J Cancer
Mueller T, Vasella F, Velz J, Voglis S, Akeret K, Padevit L, Schubert M, Weller J, Brüningk S, Rushing E, Sarnthein J, Gramatzki D, Häni L, Raabe A, Zeitlberger AM, Bozinov O, Le Rhun E, Weller M, Regli L, Neidert MC.   +19 more
europepmc   +1 more source

Dual inhibition of xCT and GGCT induces ferroptosis in glioblastoma cells by depleting cysteine and disrupting redox homeostasis. [PDF]

Cell Death Discov
Mori M, Ii H, Matsumura M, Sone Y, Kumamoto H, Sakurai K, Fujino T, Nihei N, Hongo N, Nose K, Matsumoto T, Fujita M, Nakata S.   +12 more
europepmc   +1 more source

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series. [PDF]

Vaccines (Basel)
Esparragosa Vázquez I, López-Díaz de Cerio A, Inoges S, Aristu J, Domínguez P, García-Eulate R, Calvo-Imirizaldu M, Arbizu J, Rodríguez-Ruiz ME, Irimia P, Alonso MM, Prósper F, Díez-Valle R, Gállego Pérez-Larraya J.   +13 more
europepmc   +1 more source

Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses. [PDF]

Oncotarget
Ahmed K, N X Fa X F Ez-R X Ed Os JE.
europepmc   +1 more source

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center. [PDF]

J Neurooncol
Pack E, Cifarelli CP, Bhatia S, Lewis J, Brandmeir N, Gleckman A, Han PC, Wages NA, Dotson TS, Denney MW, Wen S, Armistead M, Norouzi S, Aulakh S.   +13 more
europepmc   +1 more source